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Objective: To discuss the role of intestinal ﬂora imbalance in the pathogenesis of
pouchitis.
Methods: The pouchitis rat model was established and the faeces sample and the mucous
membrane sample were collected regularly, in which the bacterial nucleic acids were
extracted for quantitative analysis of the intestinal ﬂora in the samples through using the
real-time quantitative PCR technique and high energy sequencing technology.
Results: The disorder phenomenon of the intestinal ﬂora appeared at the 7th day of the
experiment, and the pouchitis was presented at the 21st day of the experiment. At the 31st
day of the experiment, compared to control group and non-pouchitis group, the quantity
of Biﬁdobacterium and the Lactobacillus of the pouchitis model rats in the mucous
membrane sample and the faeces sample were signiﬁcantly decreased (P < 0.05), and the
Bacteroidetes, Faecalibacterium prausnitzii and XIV Clostridium leptum subgroup in the
mucous membrane of pouchitis were signiﬁcantly decreased (P < 0.05). The IV Clos-
tridium coccoides group was the main ﬂora in the mucous membrane of pouchitis, the
bacterial diversity of non-pouchitis group and control group was signiﬁcantly higher than
that of the pouchitis group (P < 0.05).
Conclusions: The intestinal ﬂora imbalance is one of the factors that cause the incidence
of the pouchitis; this study provides a clue of the pathogenesis and treatment direction of
the intestinal inﬂammatory disease.1. Introduction
The incidence rate of pouchitis of ulcerative colitis after the
operation is 50%, and it will increase with the extension of time.
There are 61% of the patients who are multiple attacked by this
disease, and 5%–19% of the patients will develop into chronic
pouchitis [1,2]. There are many similarities of the phenotype of
the pouchitis, crohn disease and ulcerative colitis, which isthat the individual predisposing gene is activated through the
factors of infection and surroundings, and cause the abnormity
of the tolerance of intestinal immune, hence leading to the
continuous and sustained inﬂammatory reactions and damage
of tissues [3–5].
Pouchitis is the intestinal inﬂammatory disease that can be
expected, which is an uncommon model of intestinal inﬂam-
matory disease that can be follow-up researched from premorbid
[6]. Therefore, pouchitis is seen as the research object to study
and discuss the cause and effect relationships between the
changes of the intestinal ﬂora and the incidence of the
inﬂammation, so as to not only providing new method and
clue for the prevention and treatment of pouchitis, but also
offering a clue to the pathogenesis study of crohn disease and
ulcerative colitis. So far, the relationship between the intestinal
ﬂora imbalance and the pathogenesis of pouchitis is not clear
yet. We establish pouchitis rat model, the expected intestinal
inﬂammatory disease model to dynamically test the changes ofrticle under the CC BY-NC-ND license (http://
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Real-time PCR quantitative techniques to discuss its mechanism
of action in the intestinal inﬂammatory reaction, and provide a
clue of the pathogenesis and treatment direction of the intestinal
inﬂammatory disease.
2. Materials and methods
2.1. Materials
QIAamp DNA Mini Kit and Real-time PCR were purchased
from Qiagen Co., Ltd.; the extraction kits of bacterial genome
DNA were purchased from Tiangen BioTech Co., Ltd. A total of
70 SPF grade male Lewis rats with body weight of 300–325 g
were purchased from Animal Experiment Center of Shanghai
Jiao Tong University. This experiment was approved by Ethics
Committee of Jinling hospital, and all operations were strictly
abided by the speciﬁcations of Regulation of Experimental
Animals. The experimental operations were ﬁnished at Depart-
ment of Comparative Medicine, Jinling Hospital, and the oper-
ation of gene detection was ﬁnished at State Key Laboratory of
infectious disease diagnosis and treatment, First Afﬁliated
Hospital of Medical School of Zhejiang University.
2.2. Methods
2.2.1. Establishment of experimental ileoanal pouch rat
model
A total of 50 Lewis male rats with body weight of 300–325 g
were fed in a simulation environment with constant temperature.
The rats were fed with standard rodent's foodstuff in the meta-
bolism cages of 5–7 d in order to adapt to the cages before the
operation. They were fasted before 24–36 h of the operation, and
their drinking water was replaced with 5% glucose solution to
avoid the delay of the healing of anastomotic stoma caused by
high catabolism state. The rats were anesthetized with intra-
muscular injection without using antibiotics before the opera-
tion, then the intestinum crassum was resected after opening
operation, and ileoanal pouch was established to coincide with
rectum, then the abdominal cavity was closed. The operations
were all conducted in the aseptic conditions. The rats were put
on the water jacket heating pad 24 h after the operation, then
they were put into metabolism cages after 24 h for 4 d and fed
with 5% glucose solution only; they were fed with rodent's
foodstuff soaked with glucose at the 6th day of the operation,
and fed with standard rodent's foodstuff after they had tolerance
of the food soaked with glucose. A total of 20 SD normal male
rats were selected as control group, and their general conditions
were observed and recorded, and all rats were executed at the
31st of the experiment and the mucous membrane samples were
collected. The faeces samples were taken out for detection every
week, and the samples were all preserved in the temperature
of −80 C.
2.2.2. Extraction of DNA of mucous membrane and total
bacteria in faeces
The cells were mechanical cracked by glass bead breaker,
and DNA of mucous membrane samples and the faeces of rats
were extracted referenced to CTAB method; the QIAamp DNA
Mini Kit (Qiagen) was used to extract the DNA of bacteria in
mucous membrane and the QIAamp DNA stool Mini Kit(Qiagen) was used to extract the DNA of the faeces. All oper-
ations were strictly abided by the product speciﬁcations, and all
the DNA samples were preserved in the temperature of −20 C.
2.2.3. 16S rRNA PCR analysis and 454 high-throughput
sequencing of intestinal bacteria
The DNA of total bacteria in faeces samples was used as
model for the PCR analysis on V6–V8 fragment of 16S rRNA
gene sequences of the bacteria, and the primers of PCR were
U968-GC and L1401 with GC clips. The DNA of total bacteria
in mucous membrane samples and faeces samples was extracted
as the model for the PCR analysis on V3–V5 fragment of 16S
rRNA gene sequences of the bacteria, the 16S rRNA fragment
V3–V5 variable region, which is the ampliﬁcation substance of
PCR, was sequenced by Sangon Biotech (Shanghai) Co., Ltd.
through 454 high throughput sequencing method. The sequences
after the 454 sequencing were effectively screened, and the
screening criteria showed as follow: 1) at least one fragment of
the sequence was complete matching with barcode sequence and
the primer sequence; 2) the length of the sequence was over
50 bp; 3) the number of blurry bases of the sequence was not
over 2.
2.2.4. Quantitative analysis of samples by real-time PCR
instrument
The total bacteria, Firmicutes, Bacteroidetes, IV Clostridium
coccoides (C. coccoides) group, XIV Clostridium leptum
(C. leptum) subgroup, Biﬁdobacterium and Lactobacillus in the
mucous membrane samples and faeces samples were quantita-
tively analyzed by ABI 7500 real-time PCR instrument. The
total reaction system of PCR was 20.0 mL: 10.5 mLof SYBR
Green Supermix, 0.3 mol/L of upstream primers and down-
stream primers, 1.0 mL of DNA sample and 7.8 mL of aquae
sterilisata. The represented nucleic acid of Escherichia coli,
Bacteroides thetaiotaomicron, C. coccoides, C. leptum, Faeca-
libacterium prausnitzii (F. prausnitzii), Lactobacillus sobrius
and Biﬁdobacterium longum were respectively used as model to
amplify their 16S rRNA gene, and make corresponding quan-
titative standard curve. The density of DNA of the PCR pro-
duction was detected after the puriﬁcation of the production, and
calculated its copy numbers according to the formula:
Copy = (C/X) × 0.912 × 1012. The using primers and the re-
actions of real-time PCR were showed in Table 1.
2.2.5. Data analysis and processing
After the experimental data were preliminary statistically
processed by Excel 2007, and the SPSS16.0 software was used
for the signiﬁcant analysis between pouchitis group and ileoanal
pouch group through the one-way analysis of variance method.
Chi-square test and Logistic regression were used to analyze the
change over time of structure and number of intestinal ﬂora,
respectively.
3. Results
3.1. General conditions and pathological changes of
pouchitis
There was signiﬁcant weight loss, fecal occult blood positive
and diarrhea in 30 rats at the 21st day of the experiment, which
means the model was established successfully according to the
Table 1
Real-time PCR analysis of the quantity of main functional bacteria ﬂora in faeces sample at the ﬁrst day (log copy numbers/g wet weight of samples).
Group Objective bacteria
Total bacteria Bacteroidetes IV C. coccoides
group
XIV a C. leptum
subgroup
F. prausnitzii Lactobacillus Biﬁdobacterium
Control group 11.35 ± 0.25 9.26 ± 0.63 8.62 ± 0.41 9.69 ± 0.63 9.85 ± 0.26 7.79 ± 0.73 8.68 ± 0.27
Non-pouchitis group 11.64 ± 0.26 9.43 ± 0.74 8.57 ± 0.21 9.89 ± 0.35 9.86 ± 0.63 7.41 ± 0.47 8.74 ± 0.63
Pouchitis group 12.08 ± 0.31 9.13 ± 0.36 8.93 ± 0.37 9.14 ± 0.53 9.72 ± 0.29 7.08 ± 0.38 8.18 ± 0.37
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rolled into pouchitis group, and the other 20 rats without the
classical symptom in the model were rolled into non-pouchitis
group. The general conditions of the rats in control group and
non-pouchitis group were normal. And the symptoms of in-
ﬂammations, such as loss of appetite, abdominal distension, less
active, lusterless fur, sustained weight loss, diarrhea and with
blood in stool occurred to the pouchitis group.
3.2. Quantitative analysis of main intestinal ﬂora in
faeces sample
The quantitative analysis of main intestinal ﬂora in faeces
sample was shown in Tables 1 and 2. As shown in Table 1, there
was no signiﬁcant difference in main functional bacteria ﬂora in
faeces samples among the three groups (Table 1). However, on
the 31st day, compared to those of rats in control group, the
quantity of total bacteria, Firmicutes, Bacteroidetes, IV
C. coccoides group, XIV a C. leptum subgroup, Biﬁdobacte-
rium, F. prausnitzii and Lactobacillus in the faeces sample of
non-pouchitis group had no signiﬁcant difference (P > 0.05).
Compared to those of rats in non-pouchitis group and control
group, the Bacteroidetes, IV C. coccoides group, XIV C. leptum
subgroup, F. prausnitzii, Lactobacillus and Biﬁdobacterium in
the pouchitis group were signiﬁcantly different (P < 0.05), and
the Biﬁdobacterium and Lactobacillus were signiﬁcantlyTable 2
Real-time PCR analysis of quantity of main functional bacteria ﬂora in faece
Group
Total bacteria Bacteroidetes IV C. coccoides
group
Control group 11.67 ± 0.61 9.13 ± 0.72 8.23 ± 0.26
Non-pouchitis group 11.89 ± 0.32 9.27 ± 0.82 8.37 ± 0.01
Pouchitis group 12.58 ± 0.73 6.14 ± 0.24*# 14.09 ± 0.25*#
*P < 0.05 compared with the control group.
#P < 0.05 compared with the non-pouchitis group.
Table 3
Real-time PCR analysis of quantity of main functional bacteria ﬂora in mu
samples).
Group
Total bacteria Bacteroidetes IV C. coccoides
group
Control group 11.67 ± 0.61 9.13 ± 0.72 8.23 ± 0.26
Non-pouchitis group 11.89 ± 0.32 9.27 ± 0.82 8.37 ± 0.01
Pouchitis group 12.58 ± 0.73*# 6.14 ± 0.24*# 11.09 ± 0.25*#
*P < 0.05 compared with the control group.
#P < 0.05 compared with the non-pouchitis group.decreased (P < 0.05) (Table 2). The IV C. coccoides group was
the main ﬂora in the faeces sample of pouchitis with no
inﬂammation, and the enterobacterium and Streptococcus were
the main ﬂora in faeces sample of non-pouchitis; the quantity of
total bacteria had no signiﬁcant differences (P > 0.05), but the
bacterial diversity of non-pouchitis group and control group was
signiﬁcantly higher than that of the pouchitis group (P < 0.05).
3.3. Quantitative analysis of main intestinal ﬂora in
mucous membrane sample
The quantitative analysis of main intestinal ﬂora in mucous
membrane sample was shown in Table 3. Compared to the rats in
control group on the 31st day, the results showed that the quantity
of the total bacteria, Bacteroidetes, IV C. coccoides group, XIV a
C. leptum subgroup, Biﬁdobacterium, F. prausnitzii and Lacto-
bacillus in the faeces sample of non-pouchitis group was not
signiﬁcantly different (P > 0.05); compared to those of non-
pouchitis group, the total bacteria, Bacteroidetes, IV
C. coccoides group, XIV C. leptum subgroup, F. prausnitzii,
Lactobacillus and Biﬁdobacterium of rats in pouchitis group were
all signiﬁcantly different (P < 0.05), and the Biﬁdobacterium and
Lactobacillus were signiﬁcantly decreased (P < 0.05); the IV
C. coccoides group was the main ﬂora bacteria in mucous mem-
brane of pouchitis, and the enterobacterium and Streptococcus
were the main ﬂora bacteria in mucous membrane of pouchitiss sample at 31st day (log copy numbers/g wet weight of samples).
Objective bacteria
XIV a C. leptum
subgroup
F. prausnitzii Lactobacillus Biﬁdobacterium
9.85 ± 0.08 9.72 ± 0.31 7.89 ± 0.61 8.62 ± 0.31
9.97 ± 0.16 9.83 ± 0.14 7.56 ± 0.52 8.75 ± 0.51
5.72 ± 0.21*# 5.17 ± 0.21*# 4.13 ± 0.06*# 5.05 ± 0.09*#
cous membrane sample at 31st day (log copy numbers/g wet weight of
Objective bacteria
XIV a C. leptum
subgroup
F. prausnitzii Lactobacillus Biﬁdobacterium
9.85 ± 0.08 9.72 ± 0.31 7.89 ± 0.61 8.62 ± 0.31
9.97 ± 0.16 9.83 ± 0.14 7.56 ± 0.52 8.75 ± 0.51
6.72 ± 0.21*# 6.17 ± 0.21*# 5.13 ± 0.06*# 5.05 ± 0.09*#
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non-pouchitis group and control group was signiﬁcantly higher
than that of the pouchitis group.
3.4. High-throughput sequencing
The results of high-throughput sequencing was submitted to
NCBI, and through the BLAST search comparison and the
software analysis, which showed that the diversity of intestinal
ﬂora bacteria in the faeces sample and mucous membrane
sample of pouchitis group were signiﬁcantly decreased
(P < 0.05), compared to control group and non-pouchitis group.4. Discussion
The pathogenesis of inﬂammatory bowel disease (IBD) is
involved the interactions of many aspects, such as heredity,
immune, intestinal ﬂora and environment. Some clinical exper-
iments have conﬁrmed that improving the diversity of the in-
testinal ﬂora will contribute to the effective treatment of the
intestinal inﬂammation [8,9]. However, the species of the
intestinal ﬂora were numerous, and the sensibility and the
speciﬁcity of traditional separation and identiﬁcation method
were not high, which can only quantitatively measure a part of
the intestinal ﬂora. 16S rRNA is a major parameter that is
used for classiﬁcation of microbial system in recent years.
This kind of ribosome RNA of prokaryotic organism has both
the conserved sequence and high variable sequence, and the
PCR primer was used to amplify DNA according to the
speciﬁcity of this genus design, which can be used for
quantitative detection of the intestinal ﬂora. The speciﬁcity
and the sensitivity of the technical evaluation of PCR to the
intestinal ﬂora are higher than those of the traditional methods.
According to the general trend, the application of 16s rRNA
technique in the ﬁeld of ﬂora analysis will be more and more
extensive.
Pouchitis is the common complication after the operation of
ulcerative colitis, and the pathogenesis is still not clear [10,11].
Similar to the IBD, its pathogenesis process involves intestinal
ﬂora imbalance, but it is not clear that these changes are the
initial alteration factors or the secondary changes of intestinal
inﬂammation environment [12–18]. Real-time PCR technique
was used to amplify 16s rRNA to dynamically monitor the
changes of the intestinal ﬂora of rats in pouchitis model and rats in
control group during the process of construction, which conﬁrm
that the changes of intestinal ﬂora happens before the incidence of
pouchitis, indicating that the changes of intestinal ﬂora might be
one of the factors that cause the incidence of the pouchitis.
The previous research showed that the plate count of lacto-
bacilli, Clostridium perfringens, Bacteroides, Biﬁdobacterium
groups, enterococci and coliforms in pouchitis after the operation
of ulcerative colitis had no signiﬁcant differences [19], but the
quantity of sulfate reducing bacteria in the faeces of the patients
with pouchitis after the UC operation was signiﬁcantly higher
than that of the patients with no inﬂammation, previous
inﬂammation and the patients who had received the treatment of
antibiotics [20–22]. Another research of comparative before and
after the treatment showed that the quantity of Clostridium
perfringens and aerobe were signiﬁcantly increased and the
quantity of Lactobacillus and anaerobion were decreased during
the period of activity of pouchitis [23].The quantity of Lactobacillus and anaerobion were recovered
to the normal standard after the inﬂammation was relieved
through antibiotics treatment [24,25]. The same kind of research
had also found that the quantity of Lactobacillus and
Biﬁdobacterium during the period of activity of pouchitis was
signiﬁcantly decreased compared to the relieved period [26].
The results of this study had also proved this point.
Based on the previous research of 16s RNA molecular bio-
logical techniques, the ﬁngerprinting techniques was applied to
the comparison of the mucous membrane of pouchitis and the
mucous membrane of ileoanal pouch and found that
C. coccoides group was the main ﬂora in the mucous membrane
of pouchitis and the enterobacterium and Streptococcus were the
main ﬂora in the mucous membrane of ileoanal pouch [18]. The
structure of intestinal ﬂora of pouchitis was analyzed by another
terminal restriction fragment length polymorphism technique (T-
RFLPL) and found that IV C. coccoides group was the main
ﬂora in the mucous membrane of pouchitis [22]. It was found
that the abundance of IV C. coccoides group in pouchitis
model sample was signiﬁcantly increased in this study.
One research of the treatment of intestinal ﬂora of pouchitis
through probiotics had found that the diversity of the ﬂora in
mucous membrane of pouchitis during the relieved period was
increased and the diversity of fungus was decreased [25], which
was consistent with what had been observed in this study. This
study had found that diversity of the ﬂora in non-pouchitis group
and control group was signiﬁcantly higher than that in the
pouchitis group, the Proteobacterium in mucous membrane of
ileoanal pouch was signiﬁcantly increased, Bacteroidetes,
F. prausnitzii and XIV C. leptum subgroup were signiﬁcantly
decreased, indicating that the intestinal mucosa inﬂammation
might be negative related to diversity of the ﬂora, and the
decrease of the diversity of ﬂora was happened before the
symptoms of pouchitis, indicating that the decrease of the di-
versity of intestinal ﬂora was one of the reasons that caused the
pouchitis.
Although many researches had found that there were changes
of many related ﬂora and bacteria species in the intestinal in-
ﬂammatory diseases, and even the relationships of some speciﬁc
bacteria and the incidence of the diseases were conﬁrmed,
however, it was still not clear that these changes were the initial
alteration factors of the incidence of intestinal inﬂammation or
the secondary changes under the environment of the intestinal
inﬂammation [27–30]. This study has conﬁrmed that the changes
of the intestinal ﬂora happen before the intestinal inﬂammation
and it is not the secondary changes, which is not only
signiﬁcant for illuminating the pathogenesis of the intestinal
inﬂammatory disease, but also provides a clue of the
pathogenesis and treatment direction for the intestinal
inﬂammatory disease.
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